Developer docs
API playgroundTry for free, no card

Search company profiles

Summit Clinical Research

Full company profile

uuid0007exy

Namestring
Summit Clinical Research
Legal namestring
Summit Clinical Research, LLC
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Summit Clinical Research is a privately held Integrated Research Organization (IRO) headquartered in San Antonio, Texas, founded in 2018 by Dr. Stephen Harrison and Gail Hinkson to accelerate clinical trial execution in metabolic liver disease. The company specializes in therapeutically focused clinical research services for pharmaceutical and biotechnology sponsors, with a core concentration in Steatotic Liver Disease (MASH/MASLD), and an expanding footprint in obesity and Alzheimer's disease. Summit operates a curated network of 120+ research sites across 9 countries (United States, Mexico, Dominican Republic, Argentina, Chile, France, Germany, Italy, and the United Kingdom) and reports 70+ sponsors, 60+ projects, 71 trials, and 5,701+ enrolled patients since inception.

Summit's core technology and service portfolio comprises seven integrated offerings: Clinical Research Support Services (site recruitment, study oversight, expedited start-up), Site Support Services (operational, KOL, HR/staffing, quality control support), Central Recruitment and Retention Services (running on a customizable patient engagement platform with embedded pre-screening questionnaires), the Center of Learning (medical education and scientific communications), Biostatistics and Statistical Programming (SDTM/ADaM, regulatory submissions), Medical Sciences (clinical and medical support across SLD/obesity/Alzheimer's), and a Therapeutic Area Preceptorship Program. The platform is differentiated by a customizable pre-screening and patient engagement layer rather than proprietary AI/ML infrastructure; AI capability is sourced primarily through the 2021 PathAI partnership for digital pathology in NASH trials. Revenue is generated on a project-based, multi-year professional services model with quote-based pricing negotiated directly with sponsors.

The company is privately held following a 2022 private equity investment from LongueVue Capital and operates as a Texas LLC. In May 2026, Summit unified with Pinnacle Clinical Research under the Summit Clinical Research Solutions master brand, creating five coordinated platforms: Pinnacle (14-site owned research network), Elevation (IRO services and global partner-site network), Apogee (centralized patient recruitment), Ascend (medical communications), and Apex (early-phase CRO). The company's go-to-market is enterprise field sales combined with a community-led KOL engagement model, anchored by Chief Scientific Officer Dr. Mazen Noureddin and Chief Academic Officer Dr. Naim Alkhouri, and supported by participation across EASL, AASLD, SCOPE, MASH-TAG, Obesity Week, and AD/PD conferences.

Short descriptiontext

Summit Clinical Research is a privately held Integrated Research Organization (IRO) that runs therapeutically focused clinical trials in MASH/MASLD, obesity, and Alzheimer's for pharma and biotech sponsors, operating a 120+ site network across 9 countries and delivering site support, recruitment, biostatistics, and medical communications services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSan Antonio, United States
HQ citystring
San Antonio
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, integrated research organization, patient recruitment, medical education communications, biostatistics programming
Industry3 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Health Services8000
Product category
Clinical Research Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Research Services
TypeProfessional Services
Description

Summit Clinical Research provides comprehensive clinical research support services to pharmaceutical and biotechnology companies on a project/fee-for-service basis. Services include scientific and logistical consultation, study oversight, site enrichment services, and patient recruitment support for clinical trials. Revenue is generated through service contracts with drug sponsors for trial execution.

summitclinicalresearch.com
2Medical Education and Communications Services
TypeProfessional Services
Description

The Center of Learning provides medical education and communications services to sponsors and industry partners. Services include strategic development, scientific communication, evidence generation, digital multichannel solutions, social media, external engagement, scientific writing, and education and training.

summitclinicalresearch.com
3Biostatistics and Statistical Programming Services
TypeProfessional Services
Description

Dedicated biostatistics and statistical programming services tailored specifically for sponsors engaged in SLD, Obesity, and Alzheimer's studies. Services include protocol review, SDTM/ADaM dataset creation, statistical analysis plan development, and regulatory submission support.

summitclinicalresearch.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom project-based pricing for clinical research services
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is negotiated on a per-project basis with pharmaceutical and biotech sponsors. Each engagement is tailored to the specific trial requirements, therapeutic area, geographic scope, and service components needed.

summitclinicalresearch.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 6 records shown
1Pinnacle
Description

A 14-site integrated research network recognized for leadership in MASH, metabolic disease, obesity, Alzheimer's disease, and other complex therapeutic areas.

summitclinicalresearch.com
+5 more records
Core offering1 text field

Summit Clinical Research is an Integrated Research Organization (IRO) that delivers comprehensive clinical research services to pharmaceutical and biotechnology companies, including scientific and logistical consultation, study oversight, site enrichment, patient recruitment and retention, biostatistics, and medical education. The company specializes in Steatotic Liver Disease (MASH/MASLD), obesity, and Alzheimer's disease, operating a vetted global site network of 120+ research sites across 9 countries as the delivery backbone for sponsor trials.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Summit sites account for 12-26% of sites but contribute 25-44% of screens and enrollments in MASH trials
+3 more records
Product overview1 text field

Summit Clinical Research Solutions is a unified integrated clinical research organization comprising five coordinated platforms: Pinnacle (a 14-site integrated research network), Elevation (IRO services and global partner-site network), Apogee (centralized patient recruitment), Ascend (medical communications), and Apex (early-phase CRO). The organization provides a comprehensive suite of clinical research services including clinical research support, site support, central recruitment, medical education (Center of Learning), biostatistics, medical sciences, and preceptorship programs. Summit focuses on therapeutic areas including Steatotic Liver Disease (MASH/MASLD), obesity, and Alzheimer's disease, with a network spanning 120+ sites across 8 countries.

Product and service1 record
1Clinical Research Support Services
CategoryClinical research services
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-27
Description

Summit Clinical Research and Pinnacle Clinical Research unified under Summit Clinical Research Solutions in May 2026, creating a fully integrated clinical research platform. The combined organization delivers unified ecosystem spanning site operations, partner-site networks, patient recruitment, medical communications, and early phase CRO services. Pinnacle operates 14 sites and has been a significant contributor, accounting for approximately 25% of trial sites and 40%+ of enrolled patients.

2NAIL-NIT Consortium
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2023-06-15
Description

Summit Clinical Research collaborated with the NAIL-NIT Consortium to present groundbreaking data at the EASL Conference from over 5,000 patients combined from multiple clinical trials. This collaboration supports data generation and scientific advancement in liver disease research.

summitclinicalresearch.com
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2022-11-03
Description

Alimentiv and Summit Clinical Research announced a collaboration in November 2022 to drive Non-Alcoholic Steatohepatitis (NASH) clinical trials. This partnership combines Alimentiv's therapeutic expertise with Summit's site network and operational capabilities.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2021-09-22
Description

PathAI and Summit Clinical Research launched a comprehensive NASH clinical trial services solution in September 2021 to optimize trial success. The partnership integrates PathAI's AI-powered pathology solutions with Summit's site network and operational expertise.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Joseph Galati, Medical Director of the Sherrie and Alan Conover Center for Liver Disease & Transplantation at Houston Methodist Hospital, joined Pinnacle Clinical Research and Summit Clinical Research to expand liver research in Houston. This partnership strengthens clinical trial capabilities at the Texas Medical Center.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

ICON is one of the largest global CROs (formed via PRA Health Sciences acquisition) with extensive biotech/sponsor relationships that overlap with Summit's MASH/obesity customer base.

TypeDirect peer
Description

Elligo is a direct IRO peer that combines a site network with research services to accelerate clinical trials for sponsors, operating a comparable model to Summit's integrated approach.

TypeBroad incumbent
Description

Syneos is a large biopharmaceutical services organization combining CRO and commercial capabilities, with a broad therapeutic portfolio that overlaps with Summit's sponsor target market.

TypeBroad incumbent
Description

IQVIA is the largest global CRO with end-to-end clinical development services and proprietary data assets, setting the competitive ceiling and pricing benchmark for specialized IROs like Summit.

TypeBroad incumbent
Description

Medpace is a profitable, mid-sized full-service CRO that increasingly competes in metabolic and liver disease trials, offering a broader Phase I-IV footprint than Summit.

TypeDirect peer
Description

Worldwide is a mid-size global CRO with strong therapeutic expertise in metabolic and CNS diseases, competing for the same MASH, obesity, and Alzheimer's trial mandates as Summit.

TypeEmerging player
Description

Clario provides clinical trial endpoint technology and decentralized trial services, often partnering with or competing against IROs like Summit on data quality and patient-centric trial delivery.

TypeDirect peer
Description

Advanced Clinical is a mid-size CRO providing clinical research services across multiple therapeutic areas, comparable in scale to Summit and competing for similar biotech sponsor mandates.

TypeDirect peer
Description

Alimentiv is a strategic partner of Summit in NASH trials and a comparable GI/hepatology-focused CRO with therapeutic-area expertise and a site network serving similar sponsors.

TypeDirect peer
Description

Velocity operates an integrated site network offering Phase II-IV clinical trial services across multiple therapeutic areas, mirroring Summit's site-network + central-services model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Summit Clinical Research

Clinical Research Servicessummitclinicalresearch.com

Summit Clinical Research is a privately held Integrated Research Organization (IRO) that runs therapeutically focused clinical trials in MASH/MASLD, obesity, and Alzheimer's for pharma and biotech sponsors, operating a 120+ site network across 9 countries and delivering site support, recruitment, biostatistics, and medical communications services.

What Summit Clinical Research does

Summit Clinical Research is a privately held Integrated Research Organization (IRO) headquartered in San Antonio, Texas, founded in 2018 by Dr. Stephen Harrison and Gail Hinkson to accelerate clinical trial execution in metabolic liver disease. The company specializes in therapeutically focused clinical research services for pharmaceutical and biotechnology sponsors, with a core concentration in Steatotic Liver Disease (MASH/MASLD), and an expanding footprint in obesity and Alzheimer's disease. Summit operates a curated network of 120+ research sites across 9 countries (United States, Mexico, Dominican Republic, Argentina, Chile, France, Germany, Italy, and the United Kingdom) and reports 70+ sponsors, 60+ projects, 71 trials, and 5,701+ enrolled patients since inception.

Summit's core technology and service portfolio comprises seven integrated offerings: Clinical Research Support Services (site recruitment, study oversight, expedited start-up), Site Support Services (operational, KOL, HR/staffing, quality control support), Central Recruitment and Retention Services (running on a customizable patient engagement platform with embedded pre-screening questionnaires), the Center of Learning (medical education and scientific communications), Biostatistics and Statistical Programming (SDTM/ADaM, regulatory submissions), Medical Sciences (clinical and medical support across SLD/obesity/Alzheimer's), and a Therapeutic Area Preceptorship Program. The platform is differentiated by a customizable pre-screening and patient engagement layer rather than proprietary AI/ML infrastructure; AI capability is sourced primarily through the 2021 PathAI partnership for digital pathology in NASH trials. Revenue is generated on a project-based, multi-year professional services model with quote-based pricing negotiated directly with sponsors.

The company is privately held following a 2022 private equity investment from LongueVue Capital and operates as a Texas LLC. In May 2026, Summit unified with Pinnacle Clinical Research under the Summit Clinical Research Solutions master brand, creating five coordinated platforms: Pinnacle (14-site owned research network), Elevation (IRO services and global partner-site network), Apogee (centralized patient recruitment), Ascend (medical communications), and Apex (early-phase CRO). The company's go-to-market is enterprise field sales combined with a community-led KOL engagement model, anchored by Chief Scientific Officer Dr. Mazen Noureddin and Chief Academic Officer Dr. Naim Alkhouri, and supported by participation across EASL, AASLD, SCOPE, MASH-TAG, Obesity Week, and AD/PD conferences.

Summit Clinical Research firmographics

Firmographics
Name
Summit Clinical Research
Legal name
Summit Clinical Research, LLC
Website
https://summitclinicalresearch.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Summit Clinical Research is a privately held Integrated Research Organization (IRO) that runs therapeutically focused clinical trials in MASH/MASLD, obesity, and Alzheimer's for pharma and biotech sponsors, operating a 120+ site network across 9 countries and delivering site support, recruitment, biostatistics, and medical communications services.
Ownership category
akta.pro rank

Summit Clinical Research industry classification

Industry
Product category
Clinical Research Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)

Keywords

  • Clinical research services
  • Integrated research organization
  • Patient recruitment
  • Medical education communications
  • Biostatistics programming

Where Summit Clinical Research is headquartered

Location

Headquarters

HQ city
San Antonio
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Summit Clinical Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Research Services: Summit Clinical Research provides comprehensive clinical research support services to pharmaceutical and biotechnology companies on a project/fee-for-service basis. Services include scientific and logistical consultation, study oversight, site enrichment services, and patient recruitment support for clinical trials. Revenue is generated through service contracts with drug sponsors for trial execution.
  2. Medical Education and Communications Services: The Center of Learning provides medical education and communications services to sponsors and industry partners. Services include strategic development, scientific communication, evidence generation, digital multichannel solutions, social media, external engagement, scientific writing, and education and training.
  3. Biostatistics and Statistical Programming Services: Dedicated biostatistics and statistical programming services tailored specifically for sponsors engaged in SLD, Obesity, and Alzheimer's studies. Services include protocol review, SDTM/ADaM dataset creation, statistical analysis plan development, and regulatory submission support.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing for clinical research services

Go-to-market motion2 records

Distribution channels2 records

Marketing channels10 records

Summit Clinical Research product offering

Product offering

Core offering

Summit Clinical Research is an Integrated Research Organization (IRO) that delivers comprehensive clinical research services to pharmaceutical and biotechnology companies, including scientific and logistical consultation, study oversight, site enrichment, patient recruitment and retention, biostatistics, and medical education. The company specializes in Steatotic Liver Disease (MASH/MASLD), obesity, and Alzheimer's disease, operating a vetted global site network of 120+ research sites across 9 countries as the delivery backbone for sponsor trials.

Product overview

Summit Clinical Research Solutions is a unified integrated clinical research organization comprising five coordinated platforms: Pinnacle (a 14-site integrated research network), Elevation (IRO services and global partner-site network), Apogee (centralized patient recruitment), Ascend (medical communications), and Apex (early-phase CRO). The organization provides a comprehensive suite of clinical research services including clinical research support, site support, central recruitment, medical education (Center of Learning), biostatistics, medical sciences, and preceptorship programs. Summit focuses on therapeutic areas including Steatotic Liver Disease (MASH/MASLD), obesity, and Alzheimer's disease, with a network spanning 120+ sites across 8 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Pinnacle: A 14-site integrated research network recognized for leadership in MASH, metabolic disease, obesity, Alzheimer's disease, and other complex therapeutic areas.
  • Elevation
  • Apogee
  • Ascend
  • Apex
  • Cirrhosis Advisory Board

Products and services

  • Clinical Research Support Services

Quantifiable outcome

  • Summit sites account for 12-26% of sites but contribute 25-44% of screens and enrollments in MASH trials
  • +3 more outcomes

Companies that use Summit Clinical Research

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Summit Clinical Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Summit Clinical Research partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered flagship, strategic and core.

  • Pinnacle Clinical ResearchflagshipStrategic or Co-development Partner · 27 May 2026Summit Clinical Research and Pinnacle Clinical Research unified under Summit Clinical Research Solutions in May 2026, creating a fully integrated clinical research platform. The combined organization delivers unified ecosystem spanning site operations, partner-site networks, patient recruitment, medical communications, and early phase CRO services. Pinnacle operates 14 sites and has been a significant contributor, accounting for approximately 25% of trial sites and 40%+ of enrolled patients.
  • NAIL-NIT ConsortiumstrategicStrategic or Co-development Partner · 15 June 2023Summit Clinical Research collaborated with the NAIL-NIT Consortium to present groundbreaking data at the EASL Conference from over 5,000 patients combined from multiple clinical trials. This collaboration supports data generation and scientific advancement in liver disease research.
  • AlimentivstrategicStrategic or Co-development Partner · 3 November 2022Alimentiv and Summit Clinical Research announced a collaboration in November 2022 to drive Non-Alcoholic Steatohepatitis (NASH) clinical trials. This partnership combines Alimentiv's therapeutic expertise with Summit's site network and operational capabilities.
  • PathAIstrategicStrategic or Co-development Partner · 22 September 2021PathAI and Summit Clinical Research launched a comprehensive NASH clinical trial services solution in September 2021 to optimize trial success. The partnership integrates PathAI's AI-powered pathology solutions with Summit's site network and operational expertise.
  • Houston Methodist HospitalcoreStrategic or Co-development PartnerDr. Joseph Galati, Medical Director of the Sherrie and Alan Conover Center for Liver Disease & Transplantation at Houston Methodist Hospital, joined Pinnacle Clinical Research and Summit Clinical Research to expand liver research in Houston. This partnership strengthens clinical trial capabilities at the Texas Medical Center.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Summit Clinical Research competitors and assessment

Company assessment

Broad incumbents

  • ICON plc: ICON is one of the largest global CROs (formed via PRA Health Sciences acquisition) with extensive biotech/sponsor relationships that overlap with Summit's MASH/obesity customer base.
  • Syneos Health: Syneos is a large biopharmaceutical services organization combining CRO and commercial capabilities, with a broad therapeutic portfolio that overlaps with Summit's sponsor target market.
  • IQVIA: IQVIA is the largest global CRO with end-to-end clinical development services and proprietary data assets, setting the competitive ceiling and pricing benchmark for specialized IROs like Summit.
  • Medpace Holdings: Medpace is a profitable, mid-sized full-service CRO that increasingly competes in metabolic and liver disease trials, offering a broader Phase I-IV footprint than Summit.

Direct peers

  • Elligo Health Research: Elligo is a direct IRO peer that combines a site network with research services to accelerate clinical trials for sponsors, operating a comparable model to Summit's integrated approach.
  • Worldwide Clinical Trials: Worldwide is a mid-size global CRO with strong therapeutic expertise in metabolic and CNS diseases, competing for the same MASH, obesity, and Alzheimer's trial mandates as Summit.
  • Advanced Clinical: Advanced Clinical is a mid-size CRO providing clinical research services across multiple therapeutic areas, comparable in scale to Summit and competing for similar biotech sponsor mandates.
  • Alimentiv: Alimentiv is a strategic partner of Summit in NASH trials and a comparable GI/hepatology-focused CRO with therapeutic-area expertise and a site network serving similar sponsors.
  • Velocity Clinical Research: Velocity operates an integrated site network offering Phase II-IV clinical trial services across multiple therapeutic areas, mirroring Summit's site-network + central-services model.

Emerging players

  • Clario: Clario provides clinical trial endpoint technology and decentralized trial services, often partnering with or competing against IROs like Summit on data quality and patient-centric trial delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Summit Clinical Research social profiles

Digital presence

Summit Clinical Research compliance and trust

Trust signal

Compliance2 records

Summit Clinical Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Summit Clinical Research leadership team

Management profile

Number of profiles

Profiles7 records

Summit Clinical Research subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Summit Clinical Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Summit Clinical Research M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Summit Clinical Research

What does Summit Clinical Research do?

Summit Clinical Research is an Integrated Research Organization (IRO) that delivers comprehensive clinical research services to pharmaceutical and biotechnology companies, including scientific and logistical consultation, study oversight, site enrichment, patient recruitment and retention, biostatistics, and medical education. The company specializes in Steatotic Liver Disease (MASH/MASLD), obesity, and Alzheimer's disease, operating a vetted global site network of 120+ research sites across 9 countries as the delivery backbone for sponsor trials.

Is Summit Clinical Research a public or private company?

Summit Clinical Research is a private company. It is classified as private equity controlled and is currently operating.

When was Summit Clinical Research founded?

Summit Clinical Research was founded in 2018. It employs 51 to 100 people.

Where is Summit Clinical Research based?

Summit Clinical Research is headquartered in San Antonio, United States, in the North America region.

How does Summit Clinical Research make money?

Three revenue lines are on record. Clinical Research Services are the primary driver. The others are medical Education and Communications Services and biostatistics and Statistical Programming Services.

Who are Summit Clinical Research's main competitors?

Broad incumbents on record are ICON plc, Syneos Health, IQVIA and Medpace Holdings. Direct peers are Elligo Health Research, Worldwide Clinical Trials, Advanced Clinical, Alimentiv and Velocity Clinical Research. Clario is listed as an emerging player.

Does Summit Clinical Research have an API?

No public API is recorded for Summit Clinical Research.

What industry is Summit Clinical Research in?

Summit Clinical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LvcpartnersSummit Clinical Research Solutions Expands Pinnacle Site Network with Acquisition of Dallas Research InstituteSummit Clinical Research Solutions acquired Dallas Research Institute through its Pinnacle site network, expanding its Dallas-Fort Worth presence. DRI specializes in metabolic and liver disease trials, including MASLD and MASH, aligning with Summit's core expertise. The acquisition adds a high-quality site in a strategic market where Pinnacle operates two additional sites.PR NewswireSUMMIT CLINICAL RESEARCH SOLUTIONS EXPANDS PINNACLE SITE NETWORK WITH ACQUISITION OF DALLAS RESEARCH INSTITUTESummit Clinical Research Solutions acquired Dallas Research Institute through its Pinnacle site network, expanding its Dallas-Fort Worth presence. DRI specializes in metabolic and liver disease trials, including MASLD and MASH, and was founded in 2024. The acquisition aligns with Summit's therapeutic expertise and adds a high-quality site in a strategic market.GlobeNewswireTekton Research and Summit Clinical Research Solutions Expand Partnership, Bring MASH Trials to OhioTekton Research is expanding its partnership with Summit Clinical Research Solutions to bring metabolic dysfunction-associated steatohepatitis (MASH) clinical trials to New Carlisle, Ohio, under the supervision of Dr. Ashok Devatha. The New Carlisle site is embedded within Honey Creek Urgent Care, providing access to a high volume of patients with cardiometabolic risk factors while maintaining primary care continuity. The expansion follows the July 2025 launch of the partnership in Yukon, Oklahoma, where MASH trials are already underway.PR NewswireSummit Clinical Research and Pinnacle Clinical Research Unite as Summit Clinical Research Solutions, Creating a Fully Integrated Clinical Research PlatformSummit Clinical Research Solutions unified Summit Clinical Research and Pinnacle Clinical Research under one master brand, creating an integrated clinical research organization. The combined entity offers five platforms, with affiliated sites accounting for about 25% of trial sites and over 40% of enrolled patients. Since 2018, Summit has supported over 50 sponsors across 115 clinical trials.PR NewswireSUMMIT CLINICAL RESEARCH ACQUIRES HOUSTON RESEARCH INSTITUTE AND DEEPENS LEADERSHIP TEAM TO ACCELERATE GROWTH AND ENHANCE SCIENTIFIC EXPERTISELongueVue Capital announced on May 1, 2025 that its portfolio company Summit Clinical Research, in partnership with Pinnacle Clinical Research, completed a strategic investment in Houston Research Institute (HRI) on February 28, 2025. HRI, founded in 2022 by metabolic key opinion leaders Dr. Mazen Noureddin and the late Dr. Stephen Harrison, focuses on MASH/MASLD, cirrhosis, alcoholic liver disease, and obesity research, enhancing Summit's network of over 120 clinical trial sites. Summit simultaneously strengthened its leadership with Dr. Noureddin as Co-Chairman of the Board, Dr. Naim Alkhouri as Chief Academic Officer, and Brandon Early as President.PR NewswireSummit Clinical Research Announces Key Leadership Appointments to Drive Next Phase of GrowthSummit Clinical Research, a San Antonio-based Integrated Research Organization specializing in liver disease, obesity, and Alzheimer's clinical trials, announced key leadership appointments with Dr. Naim Alkhouri joining as Chief Academic Officer and Brandon Early joining as President. Dr. Alkhouri, a key opinion leader in MASH therapeutics, previously served as Chief Medical Officer at Arizona Liver Health, while Mr. Early joins from ICON Biotech where he led global Project Management following the acquisition of PRA Health Sciences. The company reports operating a network of 120 clinical sites that have enrolled over 50% of patients in global MASH studies, positioning these appointments to support expansion into obesity and Alzheimer's therapeutic areas.PR NewswireSummit Clinical Research Statement on Co-Founder and Chairman Dr. Stephen HarrisonSummit Clinical Research announced the death of Co-Founder and Chairman Dr. Stephen Harrison, a pioneering hepatology researcher who spent 30 years advancing treatments for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and published over 350 peer-reviewed articles with more than 50,000 citations. Dr. Harrison played an instrumental role in developing the first FDA-approved drug for MASH/MASLD and leaves behind a legacy that includes founding both Summit Clinical Research and Pinnacle Clinical Research. The company and the broader hepatology community have committed to continuing his vision and advancing his work in clinical research.PR NewswireSUMMIT CLINICAL RESEARCH (THE LEADING INTEGRATED RESEARCH ORGANIZATION IN THE MASH FIELD) TO PRESENT LEADING EDGE INSIGHTS AT THE AASLD LIVER MEETING FROM OVER 6,000 PATIENTS ACROSS MULTIPLE CLINICALSummit Clinical Research announced that four of its physicians have been selected to present research findings at the AASLD Liver Meeting in Boston, with findings derived from therapeutic trials involving over 6,000 patients. The presentations will include one oral presentation and multiple poster sessions focused on Metabolic Dysfunction-Associated Steatohepatitis (MASH) and related subjects. The company stated its network spans 100 global sites and emphasized its leadership position in liver health clinical research.PR NewswireAlimentiv et Summit Clinical Research annoncent leur collaboration pour mener des essais cliniques sur la stéatohépatite non alcoolique (NASH)Alimentiv Inc. and Summit Clinical Research, LLC announced a strategic alliance on November 3, 2022, to advance drug development programs for Non-Alcoholic Steatohepatitis (NASH), a progressive liver disease affecting approximately 35 million people worldwide with no FDA-approved treatments. The collaboration combines Alimentiv's expertise in centralized image management and clinical trial design with Summit's integrated research network of over 100 clinical trial sites across the United States, Europe, and Latin America. The alliance aims to improve clinical trial efficiency through better trial design, faster recruitment, reduced screening failure rates, and enhanced patient experience in NASH trials.